Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics.
Kyntra Bio stock last closed at $6.83, up 0.15% from the previous day, and has decreased 12.88% in one year. It has overperformed other stocks in the Biotechnology industry by 0.64 percentage points. Kyntra Bio stock is currently +40.82% from its 52-week low of $4.85, and -45.79% from its 52-week high of $12.60.
As of May 18, 2026, there are 4.05M KYNB shares outstanding. The market value of KYNB is $27.65M. In the last 24 hours, 11,100 KYNB shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy KYNB shares.
In our opinion, eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal info so you can invest in KYNB today.
Now that you have opened your account on the best stock trading app, you can securely and quickly fund your account:
Check out the video below if you need help transferring funds into your investment account.
After you have figured out the best place to buy Kyntra Bio stock, it's very important to evaluate their stock prior to investing, so you can comprehend the risk as well as the upside.
WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.
You can see all of the due diligence checks on KYNB's stock page.
You can use many financial metrics, analyses, models, and charts to gauge KYNB's true value.
Using relative valuations ratios:
You can do more valuation analysis on KYNB's stock here.
You can dive deeper into what analysts are projecting on the Kyntra Bio stock forecast page.
Last year, KYNB revenue was $7.44M. Over the last 5 year, KYNB's revenue has grown by -47.71% per year. This was slower than the Biotechnology industry average of 29.75%.
You can analyze KYNB's earnings and revenue performance here.
Over the last 12 months, insiders at KYNB have bought more shares than they have sold.
Thane Wettig, CEO of KYNB, was the latest KYNB insider to buy. They bought $19,852.00 worth of KYNB stock on May 14, 2026.
Get more info about who owns KYNB stock here.
No, Kyntra Bio doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two main options:
Hit the Open button and your broker will place your order.
If you require more help investing in stocks on eToro, click the helpful video below:
Now that you own some KYNB shares, you'll want to stay up-to-date on your new investment.
Put KYNB on a watchlist to get alerted to the latest events about your KYNB stock.
To reiterate, here are the 6 steps to buy Kyntra Bio stock:
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to monitor your new investment in Kyntra Bio, click below.